Diabetes, Vol 41, Issue 2 222-226, Copyright © 1992 by American Diabetes Association

ARTICLES

Tissue-specific regulation of basic fibroblast growth factor mRNA levels by diabetes

CW Karpen, RG Spanheimer, AL Randolph and WL Lowe
Department of Internal Medicine, University of Iowa, College of Medicine, Iowa City.

Because basic fibroblast growth factor (bFGF) is recognized as an angiogenic factor and diabetes is characterized by multiple vascular complications, including diabetic microangiopathy, we examined the regulation of tissue bFGF mRNA levels by diabetes. Diabetes was induced in male Sprague-Dawley rats by injection of 125 mg/kg body wt i.v. streptozocin (STZ), with intensive insulin therapy initiated in half of the diabetic rats. Rats were killed 96 h postinjection of STZ. Tissue bFGF and insulinlike growth factor I (IGF-I) mRNA levels were measured simultaneously with a solution hybridization-RNase protection assay. bFGF mRNA levels increased from 1.7- to 2.7-fold in eye, heart, lung, and brain from diabetic compared with buffer-injected control rats. In skeletal muscle, bFGF mRNA levels decreased to 23% of control levels, whereas bFGF mRNA levels were unchanged in kidneys from diabetic versus control rats. Changes in tissue bFGF mRNA levels were partially reversed by insulin treatment in all tissues. In contrast, IGF-I mRNA levels were significantly decreased from 15 to 50% of control levels in all tissues studied except those in brain, which decreased to only 85% of control levels. These data demonstrate that bFGF mRNA levels are altered by diabetes in a tissue-specific fashion and are consistent with the hypothesis that increased production of bFGF may contribute to the development of diabetic microangiopathy in some tissues.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R Zbinden, S Zbinden, M Billinger, S Windecker, B Meier, and C Seiler Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy Heart, October 1, 2005; 91(10): 1289 - 1293. [Abstract] [Full Text] [PDF]

				D. S. Zatechka Jr, P. F. Kador, S. Garcia-Castineiras, and M. F. Lou Diabetes Can Alter the Signal Transduction Pathways in the Lens of Rats Diabetes, April 1, 2003; 52(4): 1014 - 1022. [Abstract] [Full Text] [PDF]

				R. Knee, A. W. Li, and P. R. Murphy Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein PNAS, May 13, 1997; 94(10): 4943 - 4947. [Abstract] [Full Text] [PDF]

				K. Takeuchi, K. Takehara, K. Tajima, S. Kato, and T. Hirata Impaired Healing of Gastric Lesions in Streptozotocin-Induced Diabetic Rats: Effect of Basic Fibroblast Growth Factor J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 200 - 207. [Abstract] [Full Text]